Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Biofeedback da Variabilidade da Frequência Cardíaca nas Forças de Segurança (GNR-HRVB)

2 de novembro de 2026 atualizado por: Egas Moniz - Cooperativa de Ensino Superior, CRL

Biofeedback da Variabilidade da Frequência Cardíaca na Regulação do Stress e Prevenção do Burnout nas Forças de Segurança

This exploratory study evaluates the effectiveness of a 12-session Heart Rate Variability Biofeedback (HRV-BFB) protocol in reducing distress and burnout while promoting psychological well-being among Portuguese National Republican Guard (GNR) professionals. Exposed to high occupational stress from unpredictable risks, shift work, and limited resources, these individuals face elevated vulnerability to chronic stress outcomes. The intervention leverages real-time HRV feedback to enhance autonomic regulation, breathing techniques, and emotional self-regulation.

Visão geral do estudo

Descrição detalhada

Security forces like the GNR play a critical role in public safety but endure chronic stress from violence exposure, rapid decisions, shift rotations, and institutional resource shortages, heightening risks of distress, burnout, and impaired well-being. Distress arises when perceived threats exceed coping resources, leading to persistent negative emotions and health disruptions. Burnout manifests as exhaustion, mental distancing, and reduced efficacy from unmanaged chronic stress, with organizational impacts including absenteeism and eroded public trust. Psychological well-being encompasses multidimensional aspects like autonomy, relationships, and purpose beyond mere absence of illness. Traditional interventions face barriers such as stigma and access issues in rural GNR contexts, necessitating flexible, self-administered tools.

Intervention: HRV-BFB Protocol HRV-BFB trains participants to consciously modulate physiological responses via real-time monitoring of heart rate variability (HRV), reflecting sympathetic-parasympathetic balance. Low HRV links to mental health risks, while training targets resonance frequency breathing (~6 breaths/min or 0.1 Hz) to boost HRV amplitude, cardiac coherence, and baroreflex strength. Delivered autonomously via app post-initial guidance, the 12-session protocol requires no daily clinician oversight, enhancing accessibility for dispersed GNR personnel. Evidence shows HRV-BFB reduces stress, anxiety, depression, and burnout while fostering well-being in high-stress groups like emergency workers.

Study Objectives This exploratory trial tests whether HRV-BFB significantly lowers distress (multidimensional: physical, cognitive, emotional, behavioral), burnout levels, and boosts psychological well-being in GNR professionals. It aims to inform scalable interventions tailored to Portuguese police realities, addressing gaps in institutional support.

Tipo de estudo

Intervencional

Inscrição (Real)

38

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Setúbal, Portugal
        • GNR - Comando Terrritorial de Setúbal (GNR - Setubal Territorial Command Centre)

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 55 anos (Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  1. Operational military personnel of the Guarda Nacional Republicana (GNR) performing security, patrol, criminal investigation, or road safety duties
  2. Any military rank or professional category within operational roles
  3. Age between 18 and 55 years, inclusive
  4. Both males and females
  5. Capable of providing informed consent in Portuguese language

Exclusion Criteria:

  1. Extended sick leave or medical absence
  2. Currently involved in serious disciplinary proceedings
  3. Use, modification, or initiation of psychotropic medication (including antidepressants, anti-anxiety medications, antipsychotics, mood stabilizers) within the past 6 months

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: HRV Biofeedback Training

Participants receive 12 individual sessions of heart rate variability biofeedback (HRV-BFB) over 4 weeks (one 12-minute session every 2 days). Training is delivered using a chest-worn ECG sensor (eSense Pulse) connected to a mobile application that provides real-time visual feedback.

Participants receive a structured heart rate variability biofeedback (HRV-BFB) training protocol delivered over 4 weeks. The intervention uses a portable chest-worn ECG sensor (eSense Pulse) connected via Bluetooth to a mobile application that provides real-time visual feedback of heart rate variability. Each participant completes 12 individual sessions of 12 minutes each (one session every 2 days). Sessions take place in a quiet room and follow a standardized format: a brief preparation phase, followed by approximately 10 minutes of guided breathing at resonance frequency (around 6 breaths per minute) using a visual breathing guide. The application displays color-coded feedback indicating how closely the participant's physiological response matches the target HRV pattern, and participants are instructed to adjust their breathing and recall positive memories to maximize time in the desired state. The aim is to increase HRV, strengthen parasympathetic activation, and improve stress and

Outros nomes:
  • Biofeedback de VFC
  • Treino de respiração em frequência de ressonância
Sem intervenção: Control: No Intervention

Participants receive no active intervention during the 4-week study intervention period and continue their usual duties and routines. They complete the same assessment schedule as the experimental group at baseline, 4 weeks, and 10 weeks. After completion of the final follow-up assessment, they are offered the opportunity to receive the HRV biofeedback training protocol.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Psychological Distress (Kessler Psychological Distress Scale - K10)
Prazo: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The Kessler Psychological Distress Scale (K-10) is a 10-item self-report measure assessing psychological distress over the past 30 days. Items measure anxiety and depressive symptoms on a 5-point Likert scale (1=never to 5=always). Total score range: 10-50 (higher scores indicate greater distress). Portuguese validation: α=0.91. Primary outcome is change from baseline to post-intervention (week 4) and follow-up (week 10).

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)
Change in Occupational Burnout (Burnout Assessment Tool - BAT-12)
Prazo: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The Burnout Assessment Tool Short Form (BAT-12) is a 12-item self-report measure of occupational burnout across 4 dimensions: exhaustion (3 items), mental distance (3 items), cognitive impairment (3 items), emotional impairment (3 items). 5-point Likert scale (1=never to 5=always). Total score range: 12-60. Portuguese validation: α=0.85. Primary outcome is change from baseline to post-intervention and follow-up.

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)
Change in Psychological Well-Being (WHO-5 Well-Being Index)
Prazo: Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

The WHO-5 Well-Being Index is a 5-item self-report measure of psychological well-being over the past 2 weeks. Items assess positive mood, vitality, sleep, daily functioning, and life satisfaction on a 0-5 scale. Total score range: 0-25 (higher=higher well-being). Primary outcome is change from baseline to post-intervention and follow-up.

Baseline (Week 0), Post-intervention (Week 4), Follow-up (Week 10)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
SDNN (Standard Deviation of NN Intervals) - Heart Rate Variability
Prazo: Baseline (Week 0), after each of 12 training sessions

SDNN measures the standard deviation of the average NN (R-R) intervals in milliseconds during a recording period. It is a general indicator of overall heart rate variability and reflects the body's overall capacity for physiological adaptation and autonomic flexibility. Higher SDNN values indicate better autonomic regulation.

Baseline (Week 0), after each of 12 training sessions
RMSSD (Root Mean Square of Successive Differences) - Parasympathetic Activity
Prazo: Baseline (Week 0), after each of 12 training sessions

RMSSD measures the root mean square of successive differences between adjacent NN (R-R) intervals in milliseconds. It is a primary time-domain measure of high-frequency heart rate variability and specifically reflects parasympathetic (vagal) nervous system activity and the body's recovery capacity. Higher RMSSD indicates stronger parasympathetic tone.

Baseline (Week 0), after each of 12 training sessions
Stress Index - Autonomic Balance Indicator
Prazo: Baseline (Week 0), after each of 12 training sessions

The Stress Index is a proprietary metric derived from heart rate variability analysis that quantifies autonomic nervous system balance. Lower values indicate better autonomic regulation and lower physiological stress levels. Higher values reflect sympathetic dominance and poorer stress adaptation.

Baseline (Week 0), after each of 12 training sessions

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

28 de janeiro de 2026

Conclusão Primária (Real)

20 de setembro de 2026

Conclusão do estudo (Real)

20 de setembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

28 de janeiro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

28 de janeiro de 2026

Primeira postagem (Real)

4 de fevereiro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

3 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

2 de novembro de 2026

Última verificação

1 de janeiro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever